Literature DB >> 26215742

Ceramide channels: destabilization by Bcl-xL and role in apoptosis.

Kai-Ti Chang1, Andriy Anishkin1, Gauri A Patwardhan2, Levi J Beverly3, Leah J Siskind4, Marco Colombini5.   

Abstract

Ceramide is a bioactive sphingolipid involved in mitochondrial-mediated apoptosis. Our data suggest that ceramides directly regulate a key initiation step in apoptosis: mitochondrial outer membrane permeabilization (MOMP). MOMP allows release of intermembrane space proteins to the cytosol, inducing the execution of the cell. Ceramides form channels in planar phospholipid membranes and outer membranes of isolated mitochondria, channels large enough to facilitate passage of proteins released during MOMP. Bcl-xL inhibits MOMP in vivo and inhibits the formation of ceramide channels in vitro. However the significance of Bcl-xL's regulation of ceramide channel formation within cells was untested. We engineered Bcl-xL point mutations that specifically affect the interaction between ceramide and Bcl-xL to probe the mechanism of ceramide channel regulation and the role of ceramide channels in apoptosis. Using these mutants and fluorescently-labeled ceramide, we identified the hydrophobic groove on Bcl-xL as the critical ceramide binding site and regulator of ceramide channel formation. Bcl-xL mutants with weakened interaction with ceramide also have reduced ability to interfere with ceramide channel formation. Some mutants have similar altered ability to inhibit both ceramide and Bax channel formation, whereas others act differentially, suggesting distinct but overlapping binding sites. To probe the relative importance of these channels in apoptosis, Bcl-xL mutant proteins were stably expressed in Bcl-xL deficient cells. Weakening the inhibition of either Bax or ceramide channels decreased the ability of Bcl-xL to protect cells from apoptosis in a stimulus-dependent manner. These studies provide the first in vivo evidence for the role of ceramide channels in MOMP.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Bax; Bcl-2; Mitochondria; Outer membrane; Sphingolipid

Mesh:

Substances:

Year:  2015        PMID: 26215742      PMCID: PMC4554889          DOI: 10.1016/j.bbamem.2015.07.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  50 in total

1.  Structure of Bax: coregulation of dimer formation and intracellular localization.

Authors:  M Suzuki; R J Youle; N Tjandra
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

2.  The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis.

Authors:  Leah J Siskind; Thomas D Mullen; Kimberly Romero Rosales; Christopher J Clarke; María José Hernandez-Corbacho; Aimee L Edinger; Lina M Obeid
Journal:  J Biol Chem       Date:  2010-02-18       Impact factor: 5.157

3.  Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel.

Authors:  Laurent M Dejean; Sonia Martinez-Caballero; Liang Guo; Cynthia Hughes; Oscar Teijido; Thomas Ducret; François Ichas; Stanley J Korsmeyer; Bruno Antonsson; Elizabeth A Jonas; Kathleen W Kinnally
Journal:  Mol Biol Cell       Date:  2005-03-16       Impact factor: 4.138

4.  Searching for the molecular arrangement of transmembrane ceramide channels.

Authors:  A Anishkin; S Sukharev; M Colombini
Journal:  Biophys J       Date:  2006-01-13       Impact factor: 4.033

5.  ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.

Authors:  Christin Tse; Alexander R Shoemaker; Jessica Adickes; Mark G Anderson; Jun Chen; Sha Jin; Eric F Johnson; Kennan C Marsh; Michael J Mitten; Paul Nimmer; Lisa Roberts; Stephen K Tahir; Yu Xiao; Xiufen Yang; Haichao Zhang; Stephen Fesik; Saul H Rosenberg; Steven W Elmore
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

6.  Ceramide channels: influence of molecular structure on channel formation in membranes.

Authors:  Meenu N Perera; Vidyaramanan Ganesan; Leah J Siskind; Zdzislaw M Szulc; Jacek Bielawski; Alicja Bielawska; Robert Bittman; Marco Colombini
Journal:  Biochim Biophys Acta       Date:  2012-02-15

Review 7.  Membrane channels formed by ceramide.

Authors:  Marco Colombini
Journal:  Handb Exp Pharmacol       Date:  2013

8.  Characteristics of isolated and purified preparations of the outer and inner membranes of mitochondria.

Authors:  D F Parsons; G R Williams; B Chance
Journal:  Ann N Y Acad Sci       Date:  1966-07-14       Impact factor: 5.691

9.  Anti-apoptotic Bcl-2 Family Proteins Disassemble Ceramide Channels.

Authors:  Leah J Siskind; Laurence Feinstein; Tingxi Yu; Joseph S Davis; David Jones; Jinna Choi; Jonathan E Zuckerman; Wenzhi Tan; R Blake Hill; J Marie Hardwick; Marco Colombini
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

10.  Bcl-XL inhibits membrane permeabilization by competing with Bax.

Authors:  Lieven P Billen; Candis L Kokoski; Jonathan F Lovell; Brian Leber; David W Andrews
Journal:  PLoS Biol       Date:  2008-06-10       Impact factor: 8.029

View more
  16 in total

Review 1.  Ceramide channels and mitochondrial outer membrane permeability.

Authors:  Marco Colombini
Journal:  J Bioenerg Biomembr       Date:  2016-01-22       Impact factor: 2.945

Review 2.  Sphingolipid metabolism in cancer signalling and therapy.

Authors:  Besim Ogretmen
Journal:  Nat Rev Cancer       Date:  2017-11-17       Impact factor: 60.716

3.  The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo.

Authors:  Lu Dai; Charles D Smith; Maryam Foroozesh; Lucio Miele; Zhiqiang Qin
Journal:  Int J Cancer       Date:  2018-01-04       Impact factor: 7.396

4.  Efficacy of Optimized Treatment Protocol Using LAU-7b Formulation against Ovalbumin (OVA) and House Dust Mite (HDM) -Induced Allergic Asthma in Atopic Hyperresponsive A/J Mice.

Authors:  Mina Youssef; Juan B De Sanctis; Cynthia Kanagaratham; Shao Tao; Eisha Ahmed; Danuta Radzioch
Journal:  Pharm Res       Date:  2020-01-08       Impact factor: 4.200

Review 5.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

6.  Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia.

Authors:  Samy A F Morad; Terence E Ryan; P Darrell Neufer; Tonya N Zeczycki; Traci S Davis; Matthew R MacDougall; Todd E Fox; Su-Fern Tan; David J Feith; Thomas P Loughran; Mark Kester; David F Claxton; Brian M Barth; Tye G Deering; Myles C Cabot
Journal:  J Lipid Res       Date:  2016-05-02       Impact factor: 5.922

7.  Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.

Authors:  Eduardo J Salustiano; Kelli M da Costa; Leonardo Freire-de-Lima; Lucia Mendonça-Previato; José O Previato
Journal:  J Biol Chem       Date:  2020-03-30       Impact factor: 5.157

8.  Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma.

Authors:  Ayse Batova; Diego Altomare; Kim E Creek; Robert K Naviaux; Lin Wang; Kefeng Li; Erica Green; Richard Williams; Jane C Naviaux; Mitchell Diccianni; Alice L Yu
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

9.  α-Mangostin protects against high-glucose induced apoptosis of human umbilical vein endothelial cells.

Authors:  Yanli Luo; Minxiang Lei
Journal:  Biosci Rep       Date:  2017-12-12       Impact factor: 3.840

10.  Role of dihydroceramides in the progression of acute-on-chronic liver failure in rats.

Authors:  Fang-Fang Li; Ning Liu; Wei Liu; Mei Li; Fan Zhang; Zhen Dong; Jin-Lan Zhang; Hua Sun
Journal:  Chin Med J (Engl)       Date:  2020-01-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.